vs
BICYCLE THERAPEUTICS PLC（BCYC）与合众银行（OSBC）财务数据对比。点击上方公司名可切换其他公司
合众银行的季度营收约是BICYCLE THERAPEUTICS PLC的2.0倍（$93.8M vs $48.0M），合众银行净利率更高（27.3% vs -42.0%，领先69.3%），过去两年BICYCLE THERAPEUTICS PLC的营收复合增速更高（56.7% vs 15.1%）
Bicycle Therapeutics是一家临床阶段生物制药企业，专注于开发双环肽类创新疗法以解决未被满足的医疗需求，核心管线覆盖肿瘤、罕见病与免疫疾病领域，在欧美布局运营，与全球头部药企达成战略合作推进候选药物落地。
合众银行是一家总部位于美国明尼阿波利斯、在特拉华州注册的美国跨国银行机构。截至2025年，它是美国第五大银行，也是美国中西部规模最大的银行，被金融稳定委员会认定为具有系统重要性的金融机构，主营银行、投资、抵押等金融服务。
BCYC vs OSBC — 直观对比
营收规模更大
OSBC
是对方的2.0倍
$48.0M
净利率更高
OSBC
高出69.3%
-42.0%
两年增速更快
BCYC
近两年复合增速
15.1%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $48.0M | $93.8M |
| 净利润 | $-20.2M | $25.6M |
| 毛利率 | — | — |
| 营业利润率 | -51.5% | — |
| 净利率 | -42.0% | 27.3% |
| 营收同比 | 1193.3% | — |
| 净利润同比 | 61.1% | 159.2% |
| 每股收益（稀释后） | $-0.29 | $0.48 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BCYCOSBC
| Q1 26 | — | $93.8M | ||
| Q4 25 | $48.0M | $95.2M | ||
| Q3 25 | $11.7M | $95.9M | ||
| Q2 25 | $2.9M | $75.1M | ||
| Q1 25 | $10.0M | $73.1M | ||
| Q4 24 | $3.7M | $73.2M | ||
| Q3 24 | $2.7M | $71.2M | ||
| Q2 24 | $9.4M | $70.8M |
净利润BCYCOSBC
| Q1 26 | — | $25.6M | ||
| Q4 25 | $-20.2M | — | ||
| Q3 25 | $-59.1M | $9.9M | ||
| Q2 25 | $-79.0M | $21.8M | ||
| Q1 25 | $-60.8M | $19.8M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-50.8M | $23.0M | ||
| Q2 24 | $-39.8M | $21.9M |
营业利润率BCYCOSBC
| Q1 26 | — | — | ||
| Q4 25 | -51.5% | 41.2% | ||
| Q3 25 | -558.6% | 13.6% | ||
| Q2 25 | -2965.8% | 38.9% | ||
| Q1 25 | -703.7% | 35.8% | ||
| Q4 24 | — | 34.7% | ||
| Q3 24 | -2385.9% | 41.9% | ||
| Q2 24 | -498.3% | 41.2% |
净利率BCYCOSBC
| Q1 26 | — | 27.3% | ||
| Q4 25 | -42.0% | — | ||
| Q3 25 | -503.7% | 10.3% | ||
| Q2 25 | -2703.8% | 29.0% | ||
| Q1 25 | -608.9% | 27.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | -1898.4% | 32.3% | ||
| Q2 24 | -425.3% | 30.9% |
每股收益（稀释后）BCYCOSBC
| Q1 26 | — | $0.48 | ||
| Q4 25 | $-0.29 | $0.53 | ||
| Q3 25 | $-0.85 | $0.18 | ||
| Q2 25 | $-1.14 | $0.48 | ||
| Q1 25 | $-0.88 | $0.43 | ||
| Q4 24 | — | $0.42 | ||
| Q3 24 | $-0.74 | $0.50 | ||
| Q2 24 | $-0.77 | $0.48 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $628.1M | $115.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $610.0M | $893.3M |
| 总资产 | $717.6M | $6.8B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BCYCOSBC
| Q1 26 | — | $115.7M | ||
| Q4 25 | $628.1M | $124.0M | ||
| Q3 25 | $648.3M | $116.5M | ||
| Q2 25 | $721.5M | $141.8M | ||
| Q1 25 | $793.0M | $256.1M | ||
| Q4 24 | $879.5M | $99.3M | ||
| Q3 24 | $890.9M | $115.8M | ||
| Q2 24 | $961.4M | $120.9M |
总债务BCYCOSBC
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $30.9M | — |
股东权益BCYCOSBC
| Q1 26 | — | $893.3M | ||
| Q4 25 | $610.0M | $896.8M | ||
| Q3 25 | $618.5M | $866.7M | ||
| Q2 25 | $668.9M | $718.6M | ||
| Q1 25 | $740.3M | $694.5M | ||
| Q4 24 | $793.1M | $671.0M | ||
| Q3 24 | $831.0M | $661.4M | ||
| Q2 24 | $873.8M | $619.3M |
总资产BCYCOSBC
| Q1 26 | — | $6.8B | ||
| Q4 25 | $717.6M | $6.9B | ||
| Q3 25 | $764.0M | $7.0B | ||
| Q2 25 | $832.2M | $5.7B | ||
| Q1 25 | $883.9M | $5.7B | ||
| Q4 24 | $956.9M | $5.6B | ||
| Q3 24 | $996.7M | $5.7B | ||
| Q2 24 | $1.1B | $5.7B |
负债/权益比BCYCOSBC
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.04× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-19.3M | — |
| 自由现金流经营现金流 - 资本支出 | $-19.9M | — |
| 自由现金流率自由现金流/营收 | -41.5% | — |
| 资本支出强度资本支出/营收 | 1.2% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-252.0M | — |
8季度趋势，按日历期对齐
经营现金流BCYCOSBC
| Q1 26 | — | — | ||
| Q4 25 | $-19.3M | $122.3M | ||
| Q3 25 | $-71.2M | $35.9M | ||
| Q2 25 | $-72.8M | $24.2M | ||
| Q1 25 | $-86.4M | $17.8M | ||
| Q4 24 | $-164.7M | $131.5M | ||
| Q3 24 | $-39.8M | $48.5M | ||
| Q2 24 | $-44.6M | $11.6M |
自由现金流BCYCOSBC
| Q1 26 | — | — | ||
| Q4 25 | $-19.9M | $117.8M | ||
| Q3 25 | $-71.8M | $34.7M | ||
| Q2 25 | $-73.3M | $23.5M | ||
| Q1 25 | $-87.0M | $16.2M | ||
| Q4 24 | $-166.0M | $120.7M | ||
| Q3 24 | $-40.3M | $46.2M | ||
| Q2 24 | $-45.0M | $8.7M |
自由现金流率BCYCOSBC
| Q1 26 | — | — | ||
| Q4 25 | -41.5% | 123.7% | ||
| Q3 25 | -612.3% | 36.2% | ||
| Q2 25 | -2509.7% | 31.2% | ||
| Q1 25 | -871.7% | 22.2% | ||
| Q4 24 | -4475.7% | 165.0% | ||
| Q3 24 | -1504.7% | 64.9% | ||
| Q2 24 | -481.2% | 12.3% |
资本支出强度BCYCOSBC
| Q1 26 | — | — | ||
| Q4 25 | 1.2% | 4.7% | ||
| Q3 25 | 5.7% | 1.3% | ||
| Q2 25 | 17.1% | 1.1% | ||
| Q1 25 | 6.1% | 2.2% | ||
| Q4 24 | 33.3% | 14.7% | ||
| Q3 24 | 16.3% | 3.3% | ||
| Q2 24 | 4.5% | 4.2% |
现金转化率BCYCOSBC
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 3.64× | ||
| Q2 25 | — | 1.11× | ||
| Q1 25 | — | 0.90× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.11× | ||
| Q2 24 | — | 0.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BCYC
暂无分部数据
OSBC
| Net Interest Income | $81.1M | 87% |
| Noninterest Income | $12.6M | 13% |
